Catalent Company Overview

What is the Stock Ticker for Catalent?

The stock ticker for Catalent is CTLT.

Where is the Catalent headquarters?

Catalent's headquarters is located in Somerset, New Jersey, United States.

What Does Catalent Do?

Catalent is a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. They offer a range of services including drug development, clinical supply services, commercial manufacturing, and packaging solutions. Their goal is to help their customers bring innovative treatments to patients faster and more efficiently.

How Does Catalent Make Money?

Catalent is a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company makes money through several revenue streams, including:

1. Development and manufacturing services: Catalent provides contract development and manufacturing services to pharmaceutical and biotech companies. This includes formulation development, clinical trial manufacturing, commercial manufacturing, and packaging services. The company charges its clients for these services, generating revenue from the fees.

2. Licensing and royalties: Catalent has a portfolio of proprietary technologies and intellectual property that it licenses to other companies. The company earns revenue from licensing fees and royalties on the sales of products that use its technologies.

3. Consumer health products: Catalent also develops and manufactures over-the-counter (OTC) and prescription consumer health products, such as vitamins, supplements, and skincare products. The company sells these products directly to consumers or through retail channels, generating revenue from product sales.

4. Clinical supply services: Catalent provides clinical supply services to support clinical trials for pharmaceutical and biotech companies. This includes packaging, labeling, and distribution of clinical trial materials. The company charges its clients for these services, generating revenue from the fees.

Overall, Catalent's revenue is generated from a combination of contract development and manufacturing services, licensing and royalties, consumer health products, and clinical supply services. The company's diversified revenue streams help to mitigate risks and provide stability to its business.

Who Founded Catalent?

Catalent was founded by John R. Misselbrook and Cornell Stamoran in 2007.

What is the History of Catalent?

Catalent is a global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company was founded in 2007 as a spin-off from Cardinal Health, a healthcare services company.

Catalent has a long history of providing innovative solutions to the pharmaceutical industry. The company's roots can be traced back to the 1930s when it was known as the Gelatin Products Corporation. Over the years, the company expanded its capabilities and product offerings, becoming a leading provider of drug delivery technologies and services.

In 1998, the company was acquired by Cardinal Health, a Fortune 500 healthcare services company. Under Cardinal Health's ownership, the company continued to grow and expand its capabilities, becoming a global leader in drug development and manufacturing.

In 2007, Catalent was spun off from Cardinal Health and became an independent company. Since then, the company has continued to grow and expand its capabilities, acquiring several companies and investing in new technologies and facilities.

Today, Catalent is a leading provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. The company has over 40 facilities worldwide and employs over 14,000 people.

What Industry is Catalent In?

Catalent is in the pharmaceuticals and biotechnology industry.

What Are Catalent's Competitive Advantages?

1. Broad range of services: Catalent offers a wide range of services including drug development, manufacturing, packaging, and delivery. This allows the company to provide end-to-end solutions to its clients, which is a significant competitive advantage.

2. Global presence: Catalent has a global presence with facilities in North America, Europe, and Asia. This allows the company to serve clients in different regions and provide localized services.

3. Technology and innovation: Catalent invests heavily in technology and innovation, which allows the company to develop new and improved drug delivery technologies. This gives the company a competitive edge in the market.

4. Regulatory expertise: Catalent has extensive regulatory expertise and experience, which is critical in the pharmaceutical industry. The company has a strong track record of successfully navigating regulatory hurdles, which is a significant competitive advantage.

5. Strong customer relationships: Catalent has strong relationships with its customers, which is a result of its focus on customer service and satisfaction. This allows the company to retain clients and win new business through referrals and recommendations.

What Are Catalent's Competitive Threats?

Some competitive threats to Catalent include:

1. Other contract development and manufacturing organizations (CDMOs) that offer similar services and capabilities.
2. In-house manufacturing capabilities of pharmaceutical companies that may choose to produce their own products instead of outsourcing to CDMOs.
3. Emerging technologies and new entrants in the market that may disrupt traditional manufacturing processes.
4. Regulatory changes and increased scrutiny that may impact the company's ability to operate and compete effectively.
5. Economic downturns or changes in healthcare policies that may reduce demand for pharmaceutical products and services.

Who Are Some of the Competitors of Catalent?

Some of the competitors of Catalent include Lonza Group, Thermo Fisher Scientific, Patheon, Recipharm, and AptarGroup.

What Are Some of Catalent's Products and Services?

Some notable products and services from Catalent include drug development and delivery solutions, clinical supply services, biologics manufacturing, oral and sterile product manufacturing, and packaging and labeling services. They also offer a range of technologies and platforms for drug delivery, such as OptiForm® Solution Suite, Zydis® Fast Dissolve Technology, and OptiDose® Design.

Has Catalent Acquired any Companies?

Yes, Catalent has made several notable acquisitions, including Accucaps Industries, Pharmatek Laboratories, and Cook Pharmica.